Cargando…

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity

Detalles Bibliográficos
Autores principales: Lausen, M., Øbro, N.F., Nielsen, B.U., Møller, R., Rossi, E., Marquart, H.V., Ostrowski, S.R., Skov, M., Pressler, T., Molin, S., Johansen, H.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184781/
http://dx.doi.org/10.1016/S1569-1993(22)00319-8
_version_ 1784724603121172480
author Lausen, M.
Øbro, N.F.
Nielsen, B.U.
Møller, R.
Rossi, E.
Marquart, H.V.
Ostrowski, S.R.
Skov, M.
Pressler, T.
Molin, S.
Johansen, H.K.
author_facet Lausen, M.
Øbro, N.F.
Nielsen, B.U.
Møller, R.
Rossi, E.
Marquart, H.V.
Ostrowski, S.R.
Skov, M.
Pressler, T.
Molin, S.
Johansen, H.K.
author_sort Lausen, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9184781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-91847812022-06-10 ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity Lausen, M. Øbro, N.F. Nielsen, B.U. Møller, R. Rossi, E. Marquart, H.V. Ostrowski, S.R. Skov, M. Pressler, T. Molin, S. Johansen, H.K. J Cyst Fibros E-Poster Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184781/ http://dx.doi.org/10.1016/S1569-1993(22)00319-8 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle E-Poster Sessions
Lausen, M.
Øbro, N.F.
Nielsen, B.U.
Møller, R.
Rossi, E.
Marquart, H.V.
Ostrowski, S.R.
Skov, M.
Pressler, T.
Molin, S.
Johansen, H.K.
ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title_full ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title_fullStr ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title_full_unstemmed ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title_short ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
title_sort eps5.01 cystic fibrosis (cf) patients chronically infected with pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
topic E-Poster Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184781/
http://dx.doi.org/10.1016/S1569-1993(22)00319-8
work_keys_str_mv AT lausenm eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT øbronf eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT nielsenbu eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT møllerr eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT rossie eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT marquarthv eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT ostrowskisr eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT skovm eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT presslert eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT molins eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity
AT johansenhk eps501cysticfibrosiscfpatientschronicallyinfectedwithpseudomonasaeruginosahavewidespreadalterationsinbothinnateandadaptiveimmunity